Concepedia

Topical Lomefloxacin 0.3% Twice Daily versus Tobramycin 0.3% in Acute Bacterial Conjunctivitis: A Multicenter Double-Blind Phase III Study

Pier Enrico Gallenga, L. Lobefalo, Laura A. Colangelo, G. Della Loggia, N. Orzalesi, Paola Velati, E. Bujtar, F. Ponte, Stefania Damiani, Massimo G. Bucci,

Ophthalmologica · 1999 · 25 citations · 5 references

DOI

Abstract

Both lomefloxacin 0.3% twice daily and tobramycin 0.3% administered 4 times daily were well tolerated and showed a high degree of clinical and microbiological efficacy in the treatment of acute bacterial conjunctivitis. Lomefloxacin caused less resistance than other antibiotics evaluated.

References

5

Lomefloxacin-induced modification of the kinetics of growth of Gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils

H. Pruul, P. J. McDonald · Journal of Antimicrobial Chemotherapy · 1990 · 45 citations

Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms

Joseph B. Richman, Heraldo Zolezio, D. Tang–Liu · Antimicrobial Agents and Chemotherapy · 1990 · 31 citations

, , +17

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing

Ronald N. Jones, Kenneth E. Aldridge, Arthur L. Barry et al. · Diagnostic Microbiology and Infectious Disease · 1988 · 31 citations

, , +7

Microbial keratitis—the false negative

Linda Ficker, C M Kirkness, Alison McCartney et al. · Eye · 1991 · 30 citations · Full text

, , +3

Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis

Kimmo Malminiemi, Osmo Kari, M. Latvala et al. · Acta Ophthalmologica Scandinavica · 1996 · 21 citations